COMMUNIQUÉS West-GlobeNewswire

Incysus Announces Appointment of Siraj Ali, MD, PhD to Its Scientific Advisory Board
30/11/2017
NEW YORK, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Incysus, Ltd., a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the treatment of cancers, today announced the addition [...]
Catalyst Pharmaceuticals, Inc. Announces Closing of Previously Announced Public Offering
30/11/2017
CORAL GABLES, Fla., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX ) today reported that it has closed its previously announced public offering of shares of its common stock. The Company [...]
The Delta Companies Promotes DeLibra Wesley to Executive VP of Operations
30/11/2017
DALLAS, Nov. 30, 2017 (GLOBE NEWSWIRE) -- The Delta Companies (TDC), a leading staffing firm for healthcare professionals nationwide, announced that DeLibra Wesley has been promoted to Executive Vice President of [...]
Block Listing Update
30/11/2017
LONDON, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq: VRNA ) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Title21 Health Solutions® to Showcase its BMT Software Solution 8.5 at the 2018 BMT Tandem Meeting
30/11/2017
PLEASANTON, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Title21 Health Solutions, “Title21”, an innovator of integrated enterprise software for blood and marrow transplant programs supporting high-quality and world-class [...]
VALNEVA Expands its Commercial Operations and Establishes US Infrastructure
30/11/2017
Valneva Expands its Commercial Operations and Establishes US Infrastructure Lyon (France), November 30, 2017 - Valneva SE, a fully integrated commercial stage biotech company focused on developing innovative, lifesaving [...]
VALNEVA poursuit le développement de ses activités commerciales avec la mise en place d'une infrastructure aux Etats-Unis
30/11/2017
Valneva poursuit le développement de ses activités commerciales avec la mise en place d'une infrastructure aux Etats-Unis Lyon (France), 30 novembre 2017 - Valneva SE, ("Valneva" ou "le Groupe"), société de [...]
Hemostemix Drives Forward with Talented New Management into New Headquarters
30/11/2017
NOT FOR DISSEMINATION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE:HEM) is pleased [...]
Intellipharmaceutics Reports on Launch of Additional Strengths of Generic Focalin XR® by Par Pharmaceutical
30/11/2017
TORONTO, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (NASDAQ: IPCI ) and (TSX: IPCI ) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, [...]
Avivagen Announces Closing of Private Placement Totaling $4 million
30/11/2017
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. OTTAWA, Nov. 30, 2017 (GLOBE NEWSWIRE) -- [...]
Sales of Olainfarm in Nine Months Reach 90.4 Million Euros
30/11/2017
Olaine, 2017-11-30 16:17 CET (GLOBE NEWSWIRE) -- AS Olainfarm just had its best third quarter in terms of sales, as company’s sales reached 27.7 million euros, representing an increase by 10%. During this quarter, the [...]
BeyondSpring Initiates Global Phase 2/3 Trial with Plinabulin in China for the Prevention of Chemotherapy-Induced Neutropenia to Demonstrate Superiority
30/11/2017
NEW YORK, Nov. 30, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ), a global clinical stage biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, today announced [...]
BioTelemetry, Inc. Enters Agreement to Provide Cardiac Monitoring for Apple’s Heart Study
30/11/2017
MALVERN, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT ), the leading mobile and wireless medical technology company focused on the delivery of health information to improve quality of life and [...]
TearLab Launches Registered Direct Offering
30/11/2017
SAN DIEGO, Nov. 30, 2017 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB:TEAR) (TSX: TLB ) (“TearLab” or the “Company”), today announced that it is launching a registered direct offering to raise gross proceeds of [...]
Symphony Health Launches New Long Term Care Channel Offering
30/11/2017
CONSHOHOCKEN, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Symphony Health , a PRA Health Sciences company and a leading provider of data, cloud-based analytics and consulting solutions to life science companies and [...]
Scythian Biosciences Corp. Completes Sale of Go Green
30/11/2017
TORONTO, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSX-V: SCYB ) (Frankfurt: 9SB ) (OTC Pink:SCCYF) is pleased to announce that it has entered into a share purchase [...]
TOMI Environmental Solutions, Inc. Joins Forces With Protak Scientific in Ground Breaking Partnership
30/11/2017
BEVERLY HILLS, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global decontamination company that specializes in disinfection/decontamination sales and services, [...]
RespireRx Pharmaceuticals Inc. Announces Publication of Phase 2B PACE Study: Once per Night Treatment with Dronabinol Provides Statistically Significant Improvement in Clinical Measures of Obstructive Sleep Apnea
30/11/2017
Glen Rock, N.J, Nov. 30, 2017 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”) announces that the results of the PACE (Pharmacotherapy of Apnea by Cannabimimetic [...]
PDMR Dealing
30/11/2017
LONDON, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq: VRNA ) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]

Pages